| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |